...
首页> 外文期刊>Case Reports in Clinical Medicine >Fertility Preservation in Premature Ovarian Insufficiency (POI) Secondary to FSH Receptor Gene (FSHR) Mutation: Is There a New Hope?
【24h】

Fertility Preservation in Premature Ovarian Insufficiency (POI) Secondary to FSH Receptor Gene (FSHR) Mutation: Is There a New Hope?

机译:FSH受体基因过早卵巢不足(POI)的生育保存(FSHR)突变:有新的希望吗?

获取原文
           

摘要

A 19 years old patient with primary amenorrhea was referred to our center. Based on discrepancy between high follicle stimulating hormone (FSH) level and normal ovarian reserve parameters, follicle stimulating hormone receptor (FSHR) mutation was screened. The patient was homozygous in exon 6 of the FSHR gene for the new variant c.479T > C and predicted to result in an aminoacid substitution p.Ile160Thr. One year later, her anti-müllerian hormone (AMH) level inexplicably decreased. Oocyte vitrification was thus offered for fertility preservation. After 17 days of recombinant follicle stimulating hormone (recFSH) (900 IU daily), no follicular growth was seen and estradiol levels remained low. In vitro maturation (IVM) was then suggested. Ten oocytes were successfully vitrified.
机译:19岁的原发性闭经的患者被提交给我们的中心。基于高卵泡刺激激素(FSH)水平和正常卵巢储备参数之间的差异,筛选卵泡刺激激素受体(FSHR)突变。患者在FSON 6的FSON 6中纯合,用于新变种C.479t> C,预测导致氨基酸替代P.ILE160THR。一年后,她的抗Müllerian激素(AMH)水平差不多减少。因此为生育保存提供了卵母细胞玻璃化。 17天的重组卵泡刺激激素(RECFSH)(每日900IU)后,没有看到卵泡生长,雌二醇水平仍然低。然后提出了在体外成熟(IVM)。十个卵ytes成功玻璃化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号